Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Cancer Cell. 2012 Jul 10;22(1):7-8. doi: 10.1016/j.ccr.2012.06.009.

The future of cancer treatment: will it include immunotherapy?

Author information

  • 1Diabetes Center, University of California San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA. jeff.bluestone@ucsf.edu

Abstract

Negative immune regulatory pathways inhibit anti-cancer T cell responses, preventing effective immune surveillance. Two clinical trials using monoclonal antibodies that antagonize the PD-1/PD-L1 pathway recently reported regression in several tumor types. In one of these trials, efficacy was linked to the expression of the PD-L1 biomarker on tumor cells.

Copyright © 2012 Elsevier Inc. All rights reserved.

Comment on

PMID:
22789534
[PubMed]

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk